The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus aureus infection and the potential for early intervention: a pilot study

Critical Care Medicine
Adam KeeneFranklin D Lowy

Abstract

To test whether a critical care consult team can be used to identify patients who have methicillin-resistant Staphylococcus aureus nasal colonization during a window period at which they are at highest risk for methicillin-resistant S. aureus infection and can most benefit from topical decolonization strategies. Prospective cohort study. Two adult tertiary care hospitals. Patients with at least one risk factor for methicillin-resistant S. aureus nasal colonization who were seen by a critical care consult team for potential intensive care unit admission were enrolled. Nasal cultures for methicillin-resistant S. aureus were performed on all subjects. All subjects were followed for the development of a methicillin-resistant S. aureus infection for 60 days or until hospital discharge. Demographic and outcome data were recorded on all subjects. Two hundred subjects were enrolled. Overall 29 of 200 (14.5%) were found to have methicillin-resistant S. aureus nasal colonization. Methicillin-resistant S. aureus infections occurred in seven of 29 (24.1%) subjects with methicillin-resistant S. aureus nasal colonization vs. one of 171 (0.6%) subjects without methicillin-resistant S. aureus nasal colonization (p < .001). Methicillin-resistan...Continue Reading

References

Jan 1, 1995·The Journal of Infectious Diseases·J A KluytmansH A Verbrugh
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J RelloR Rodriguez-Roisin
Sep 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B N DoebbelingB E Scully
Dec 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J A KluytmansH A Verbrugh
Dec 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J A KluytmansH Verbrugh
May 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·X CorbellaF Gudiol
Oct 8, 1999·Lancet·K B Kirkland, J M Weinstein
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D KalmeijerJ A J W Kluytmans
Oct 9, 2003·JAMA : the Journal of the American Medical Association·Henry Thomas StelfoxDonald A Redelmeier
Mar 17, 2004·Annals of Internal Medicine·Heiman F L WertheimHenri A Verbrugh
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Gilles TrochéJean-Fabien Zazzo
Aug 12, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Adam KeeneFranklin D Lowy
Dec 7, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I M Gould
Jul 4, 2006·American Journal of Infection Control·Louis B Rice
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Suzanne F Bradley
Mar 19, 2008·Annals of Internal Medicine·Ari RobicsekLance R Peterson

❮ Previous
Next ❯

Citations

Dec 22, 2009·Critical Care Medicine·Philippe Eggimann, Jacques Schrenzel
Sep 11, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·James A McKinnellSusan S Huang
Apr 21, 2010·Critical Care Medicine·Ariel L ShilohRichard H Savel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
M Garrouste-OrgeasJ Carlet
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
David P CalfeeDeborah S Yokoe
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Ari RobicsekLance R Peterson
© 2022 Meta ULC. All rights reserved